Cagrilintide/semaglutide
A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity
Novo Nordisk · Phase 3 · Active, not recruiting · Enrollment 400
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| CagriSema | Obesity or overweight | n/r | 16 | n/r | n/r |
| Placebo | Obesity or overweight | n/r | 16 | n/r | n/r |